Cheryl A Brewer

Summary

Publications

  1. ncbi Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group
    Cheryl A Brewer
    Division of Gynecologic Oncology, University of California Irvine Medical Center, Orange, CA 92868, USA
    Gynecol Oncol 100:385-8. 2006
  2. ncbi Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: a phase II study of the Gynecologic Oncology Group
    Cheryl A Brewer
    UMC Department of Ob Gyn, Division of Gynecologic Oncology, University of California Irvine and University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216 4505, USA
    Gynecol Oncol 103:446-50. 2006
  3. ncbi Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients
    Robert A Nagourney
    Rational Therapeutics, Inc, Long Beach, California 90806, USA
    Gynecol Oncol 88:35-9. 2003

Detail Information

Publications3

  1. ncbi Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group
    Cheryl A Brewer
    Division of Gynecologic Oncology, University of California Irvine Medical Center, Orange, CA 92868, USA
    Gynecol Oncol 100:385-8. 2006
    ..This trial was conducted to evaluate the safety and efficacy of cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix...
  2. ncbi Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: a phase II study of the Gynecologic Oncology Group
    Cheryl A Brewer
    UMC Department of Ob Gyn, Division of Gynecologic Oncology, University of California Irvine and University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216 4505, USA
    Gynecol Oncol 103:446-50. 2006
    ..To evaluate the safety and efficacy of cisplatin plus gemcitabine in persistent or recurrent platinum-resistant ovarian and primary peritoneal cancer...
  3. ncbi Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients
    Robert A Nagourney
    Rational Therapeutics, Inc, Long Beach, California 90806, USA
    Gynecol Oncol 88:35-9. 2003
    ..The aim was to determine the safety and efficacy of gemcitabine plus cisplatin for patients with relapsed ovarian carcinoma and to compare ex vivo drug sensitivity profiles with clinical outcomes...